Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Perrigo
Perrigo
Activities:
Ingredients
Pharmaceutical
Dietary supplements
Active Nutrition
Food
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Catalent client gets FDA approval for generic bronchodilator
Approval has marked the first generic metered-dose inhaler to be approved by the FDA in over twenty years and will now be scaled-up
Media
Hikma enters into licensing partnership with Perrigo in MENA
The partnership will provide significant collaboration opportunity
Finance
Mylan fails in US$26bn hostile takeover bid for Perrigo
Not enough shareholders supported the deal
Analysis
Operational cost savings for Perrigo UK
SP-4C weight checkers replace a manual sampling system
Finance
Perrigo to acquire OTC brands from GSK
In the areas of nicotine replacement therapy, cold and flu, and cold sore management
Drug Delivery
Perrigo acquires Patheon's Mexican operations for US$34m
Strengthening its capabilities with the addition of softgel manufacturing technology
Finance
Perrigo Board unanimously rejects unsolicited US$29bn bid from Mylan
Says it substantially undervalues the company and ignores key factors
Subscribe now